SEC Company Response from Beyond Air, Inc. (XAIR) (CIK 0001641631) (XAIR) — Jun 14, 2017
Beyond Air, Inc. (XAIR) (CIK 0001641631)
Date: June 14, 2017 · CIK: 0001641631 · Accession: 0001178913-17-001817
AI Filing Summary & Sentiment
File numbers found in text: 333-218626
Show Raw Text
CORRESP
1
filename1.htm
AIT Therapeutics, Inc.
2 Ilan Ramon, Science Park
Ness Ziona, 7403635 Israel
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Amanda Ravitz
Tom Jones
Re: AIT Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-218626
Ladies and Gentlemen:
AIT Therapeutics, Inc., a Delaware corporation (the "Company"), hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (the "Registration Statement") so that such Registration Statement shall become effective at 4:00 p.m. (Washington, D.C. time) on Friday, June 16, 2017 or as soon thereafter as practicable.
Please provide a copy of the Commission's order declaring the Registration Statement effective to Amir Avniel at the address first set forth above.
Respectfully yours,
AIT Therapeutics, Inc.
By:
/s/ Amir Avniel
Amir Avniel
President and Chief Operating Officer